Report of a germline double heterozygote in MSH2 and PALB2
Abstract Background Carriers with pathogenic variants in MSH2 have increased risk to develop colorectal, endometrium, ovarian, and other types of cancer. The PALB2 is associated with breast, ovarian, pancreatic, and prostate cancer. We describe the case of a 42‐year‐old female diagnosed with endomet...
Main Authors: | Konstantinos Agiannitopoulos, Eirini Papadopoulou, Georgios N. Tsaousis, Georgia Pepe, Stavroula Kampouri, Eleni Patsea, George Lypas, George Nasioulas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1242 |
Similar Items
-
Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients
by: Jiexia Zhang, et al.
Published: (2022-01-01) -
PALB2 as a factor to predict the prognosis of patients with skull base chordoma
by: Yujia Xiong, et al.
Published: (2022-09-01) -
Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
by: Kodai Abe, et al.
Published: (2021-01-01) -
Hodgkin lymphoma and Ewing sarcoma in pediatric patient carrying germline PALB2 variant: a case report and literature review
by: Jakub Czarny, et al.
Published: (2025-02-01) -
A rare PALB2 germline variant causing G2/M cell cycle arrest is associated with isolated myelosarcoma in infancy
by: Angelina Beer, et al.
Published: (2021-09-01)